Namita Thapar-backed Emcure Pharma IPO opens: GMP, price, apply or not? | News on Markets

The Namita Thapar-backed Emcure Pharma IPO has opened for subscription with a price band of Rs 594-600 per share. The IPO has received a strong response from investors, with the grey market premium (GMP) currently at Rs 200-220. Investors are advised to carefully consider their options before deciding whether to apply for this IPO.

Source link